On Fri, Jun 3, 2011 at 3:45 PM, Ken Arromdee wrote:
> On Fri, 3 Jun 2011, Yaroslav Halchenko wrote:
>>
>> 4. The software has been designed for research purposes only and has not
>> been approved for clinical use. It has not been reviewed or approved by
>> the
>> Food and Drug Administration
Retirement News Weekly Yorkton: Issue Seventeen
ISSUE #18: June 3, 2011Last Month’s Readers: 18,557. This Month’s Readers: 3,
904!
FROM RETIREE TO EMPLOYEE
Your Retirement By: Brandee Musiala
Does a silver ceiling exist? An increasing amount of retirees are deciding to
return to work
On Fri, 3 Jun 2011, Yaroslav Halchenko wrote:
4. The software has been designed for research purposes only and has not
been approved for clinical use. It has not been reviewed or approved by the
Food and Drug Administration or by any other agency. You acknowledge and
agree
that clini
Yaroslav Halchenko wrote:
> 6. We request that you acknowledge the support of XNAT in publications
> that utilize the software such as by "This product includes XNAT,
> developed by
> Randy Buckner at Harvard University and the Neuroinformatics Research
> Group at
> Washington U
Hi Comrades,
We are considering packaging XNAT [1]. Its license terms [2] look like an
apache 1.1 like license with additional disclaimers (not for clinical
use), and requests. Could you please advise either those of particular concern
forbidding XNAT entering main?
Here is the full list of ter
5 matches
Mail list logo
